SCHEMBL30914985

SCHEMBL30914985

Cc1cnc(NC2CCN(C(=O)OC(C)(C)C)CC2)nc1

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.56
MAPK1 P28482 2/20 0.55
NPC1 O15118 1/20 0.55
MAPT P10636 1/20 0.55
HTT P42858 1/20 0.55
RAB9A P51151 1/20 0.55
L3MBTL1 Q9Y468 1/20 0.55
EPHX1 P07099 1/20 0.50
GPR119 Q8TDV5 4/20 0.49
JAK1 P23458 1/20 0.48
KMT2A Q03164 1/20 0.48
SYK P43405 1/20 0.48
DDB1 Q16531 1/20 0.47
CRBN Q96SW2 1/20 0.47
USP30 Q70CQ3 1/20 0.47
IDH1 O75874 1/20 0.47
IDH2 P48735 1/20 0.47
BTK Q06187 1/20 0.47
LMNA P02545 1/20 0.47
EPHX2 P34913 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28549570 0.93 USP30 (0.53) ALDH1A1MAPK1NPC1MAPTHTT
SCHEMBL22895509 0.93 USP30 (0.53) ALDH1A1MAPK1NPC1MAPTHTT
SCHEMBL23292240 0.93 USP30 (0.53) ALDH1A1MAPK1NPC1MAPTHTT
SCHEMBL3769585 0.90 ALDH1A1 (0.56) ALDH1A1MAPK1NPC1MAPTHTT
SCHEMBL30915072 0.89 ALDH1A1 (0.57) ALDH1A1MAPK1NPC1MAPTHTT
SCHEMBL31737239 0.89 ALDH1A1 (0.55) ALDH1A1MAPK1NPC1MAPTHTT
SCHEMBL3774389 0.89 ALDH1A1 (0.55) ALDH1A1MAPK1NPC1MAPTHTT
SCHEMBL3776289 0.88 ALDH1A1 (0.54) ALDH1A1MAPK1NPC1MAPTHTT
SCHEMBL4062890 0.87 GPR119 (0.61) ALDH1A1MAPK1NPC1MAPTHTT
SCHEMBL22055496 0.86 ALDH1A1 (0.53) ALDH1A1MAPK1NPC1MAPTHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4615833-A1 BIFUNCTIONAL COMPOUNDS CONTAINING 2,5-SUBSTITUTED PYRIMIDINE DERIVATIVES FOR DEGRADING CYCLIN-DEPENDENT KINASE 2 VIA UBIQUITIN PROTEASOME PATHWAY Nikang Therapeutics, Inc. (US) 2025-09-17 EP disclosed
CN-120152967-A Bifunctional compounds containing 2, 5-substituted pyrimidine derivatives for degradation of cyclin-dependent kinase 2 via the ubiquitin proteasome pathway 霖康疗法公司 2025-06-13 CN disclosed
WO-2024102849-A1 BIFUNCTIONAL COMPOUNDS CONTAINING 2,5-SUBSTITUTED PYRIMIDINE DERIVATIVES FOR DEGRADING CYCLIN-DEPENDENT KINASE 2 VIA UBIQUITIN PROTEASOME PATHWAY NIKANG THERAPEUTICS, INC. (US) 2024-05-16 WO disclosed